CJC-1295 No DAC 10mg Research Compound

CJC-1295 No DAC is a research peptide studied for its interaction
with growth hormone-releasing hormone (GHRH) receptors. These
receptors help control the biological signals involved in growth
hormone release and downstream IGF-1 signaling.

Unlike CJC-1295 with DAC, this version does not
contain the Drug Affinity Complex designed to extend activity.
Researchers therefore use CJC-1295 No DAC when studying
shorter-duration GHRH receptor signaling and the body's natural
pulsatile pattern of growth hormone release.

Commonly Researched For

• Growth hormone-releasing hormone (GHRH) receptor signaling
• Growth hormone and IGF-1 signaling pathways
• Short-duration and pulsatile growth hormone release models
• Metabolism and body-composition research
• Muscle and tissue maintenance pathways
• Recovery-related biological signaling
• Sleep-associated growth hormone signaling
• Endocrine and hormone-signaling research

About CJC-1295 No DAC Research

Growth hormone is released through a carefully regulated signaling
system. Growth hormone-releasing hormone, or GHRH, is one of the
signals involved in telling the pituitary gland to release growth
hormone. CJC-1295 No DAC is studied because it interacts with this
GHRH signaling pathway.

Researchers examine this pathway to better understand how growth
hormone signaling influences cellular growth, metabolism, tissue
maintenance, and production of insulin-like growth factor 1
(IGF-1).

The important difference between CJC-1295 No DAC and CJC-1295 with
DAC is the duration of activity. The No DAC version does not contain
the modification designed to substantially extend the peptide's
presence in experimental models.

This makes CJC-1295 No DAC useful for laboratory models focused on
shorter periods of GHRH receptor activation and the pulse-like
signaling patterns associated with growth hormone release.

Researchers may also examine downstream changes involving
metabolism, body-composition markers, tissue maintenance, recovery
pathways, and sleep-associated hormone signaling to better
understand how shorter-duration growth hormone signaling affects
these biological systems.

In simple terms, CJC-1295 No DAC research focuses on understanding
how shorter-acting stimulation of the growth hormone signaling
system affects hormone communication, metabolism, cellular activity,
and related biological pathways.

Product Details

• Compound: CJC-1295 No DAC
• Total compound: 10mg
• Format: Lyophilized powder
• Primary research pathway: GHRH receptor signaling
• Intended use: Laboratory research only
• Application: Analytical and in-vitro research